Cancer is the most complex disease known to mankind. Bedaya By Genesis has managed to supply chemotherapy and supportive care products for government hospital and research programmers through solid long-term partnerships with global manufactures who are fast-tracking new approaches to target hard-to-treat cancers
Over the next few years, we will look to strengthen our partners network to assets in providing treatments for rare solid tumors in all stages of development
We have been delivering novel medicines for immunological diseases, which includes innovative biologic and oral therapies in core disease areas: rheumatoid arthritis, inflammatory bowel diseases and psoriasis and other autoimmune conditions that works to suppress the immune system. Also, immunosuppressive agents used to prevent graft rejection in other cases . In the other hand, Immunostimulants such as Immune globulins, vaccines are used to strengthen the or act as the body’s natural immune system.
Bedaya By Genesis is fully committed for long term to make the advancing treatment solutions in neuroscience field easy to access by local health care professionals to help people receive safe and effective treatments, support and services in spasticity in multiple sclerosis , movement disorders, Epilepsy, Migraine and specific indications in esthetic medicine.
We have been active in supplying the hospitals and clinics with latest treatments for liver, gallbladder, biliary tree, and pancreas disorders. Specifically Hepatitis C as it is the No. 1 cause of liver cancer and liver transplants and Research is moving rapidly on new treatments and some of the combinations of medications for this disease such as Ledipasvir and sofosbuvir & Glecaprevir and pibrentasvir.
Bedaya by genesis is pushing the boundaries to bring the most sophisticated treatments in the world to help in treating one of the most common disorders like Gout, Osteoarthritis and Osteoporosis and Sjogren’s Syndrome.
Although they are chronic disorders for which there is no known cure. Fortunately in the last few years, new classes of medications and regimen (NSAIDs, DMARDs, Analgesic drugs ) have greatly improved the outcomes for patients .
DMARDs: disease modifying anti-rheumatic drugs such as methotrexate, sulfasalazine, leflunomide, etanercept ,infliximab rituximab .